<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>76</volume><submitter>Gu X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Kidney damage in COVID-19 patients has been of special concern. The association of acute kidney injury (AKI) with post-acute kidney function among COVID-19 survivors was not sufficiently elucidated.&lt;h4>Methods&lt;/h4>An ambidirectional cohort study was conducted with enrollment of COVID-19 survivors discharged from hospital between Jan 7, and May 29, 2020. Study participants were invited to follow-up visits at 6 and 12 months after symptom onset. The primary outcome was percentage of estimated glomerular filtration rate (eGFR) decreased from acute phase (between symptom onset and hospital discharge) to follow-up, and secondary outcome was reduced renal function at follow-up.&lt;h4>Findings&lt;/h4>In total, 1,734 study participants were included in this study. Median follow-up dur</pubmed_abstract><journal>EBioMedicine</journal><pagination>103817</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8776508</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study.</pubmed_title><pmcid>PMC8776508</pmcid><pubmed_authors>Fan G</pubmed_authors><pubmed_authors>Gu X</pubmed_authors><pubmed_authors>Shang L</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Cui D</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Cao B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study.</name><description>&lt;h4>Background&lt;/h4>Kidney damage in COVID-19 patients has been of special concern. The association of acute kidney injury (AKI) with post-acute kidney function among COVID-19 survivors was not sufficiently elucidated.&lt;h4>Methods&lt;/h4>An ambidirectional cohort study was conducted with enrollment of COVID-19 survivors discharged from hospital between Jan 7, and May 29, 2020. Study participants were invited to follow-up visits at 6 and 12 months after symptom onset. The primary outcome was percentage of estimated glomerular filtration rate (eGFR) decreased from acute phase (between symptom onset and hospital discharge) to follow-up, and secondary outcome was reduced renal function at follow-up.&lt;h4>Findings&lt;/h4>In total, 1,734 study participants were included in this study. Median follow-up dur</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2026-07-16T14:19:18.514Z</modification><creation>2022-02-11T15:58:32.906Z</creation></dates><accession>S-EPMC8776508</accession><cross_references><pubmed>35074630</pubmed><doi>10.1016/j.ebiom.2022.103817</doi></cross_references></HashMap>